Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell’Italia Meridionale (GOIM 2802)

Autor: Maiello, Evaristo 1, ∗, Di Maggio, Gabriele 1, Cordio, Stefano 2, Cinieri, Saverio 3, Giuliani, Francesco 4, Pisconti, Salvatore 5, Rinaldi, Antonio 6, Febbraro, Antonio 7, Latiano, Tiziana Pia 1, Aieta, Michele 8, Rossi, Antonio 1, Rizzi, Daniele 9, Di Maio, Massimo 10, 11, Colucci, Giuseppe 9, Bordonaro, Roberto 2
Zdroj: In Clinical Colorectal Cancer June 2020 19(2):109-115
Databáze: ScienceDirect
Externí odkaz: